Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.
The European Directorate for the Quality of Medicines and Healthcare (EDQM) suspended or withdrew 19 certificates for active pharmaceutical ingredients in the latter half of 2010 because their manufacturers failed or refused inspections*. These are the main points:
Virtually all of the suppliers included in the list was from Asia.
The EDQM awards a CEP if the company declares GMP compliance (without a pre-approval inspection).
The EDQM conducts periodic inspections of API manufacturers, however, the EDQM has inspection capacity constraints and can only inspect about 30 sites a year.
This is important to follow, as you can expect the huge number of API suppliers to continue to come from that part of the world,
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.